|Mr. Bradley R. Mason||Chief Exec. Officer, Pres and Director||1.49M||182.8k||63|
|Mr. Doug Rice CPA||Chief Financial Officer and Chief Accounting Officer||593.33k||N/A||51|
|Mr. Michael M. Finegan||Chief Strategy Officer||680.32k||1.32M||53|
|Mr. Bradley V. Niemann||Pres of BioStim Bus.||614.96k||25.48k||47|
|Mr. Davide Bianchi||Pres of Global Extremity Fixation||677.57k||N/A||52|
Orthofix International N.V., a medical device company, provides reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. It operates through four segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to improve fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The company markets and distributes its products directly, as well as through independent distributors and independent sales representatives to hospitals, doctors, and other healthcare providers. Orthofix International N.V. was founded in 1987 and is headquartered in Lewisville, Texas.
Orthofix International N.V.’s ISS Governance QualityScore as of July 1, 2017 is 1. The pillar scores are Audit: 2; Board: 1; Shareholder Rights: 2; Compensation: 1.